Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-7,106
Closed -$706K 118
2024
Q4
$706K Sell
7,106
-20,354
-74% -$2.1M 0.14% 50
2024
Q3
$3.12M Sell
27,460
-30
-0.1% -$3.56K 0.61% 37
2024
Q2
$3.4M Hold
27,490
0.69% 38
2024
Q1
$3.63M Buy
+27,490
New +$3.39M 0.8% 38
2023
Q3
$9.22M Buy
+89,544
New +$9.65M 2.53% 13
2023
Q2
Sell
-28,482
Closed -$3.03M 149
2023
Q1
$3.03M Sell
28,482
-347
-1% -$37.5K 0.88% 38
2022
Q4
$3.19M Sell
28,829
-3
-0% -$307 0.95% 38
2022
Q3
$2.48M Sell
28,832
-280
-1% -$25K 0.49% 41
2022
Q2
$2.65M Hold
29,112
0.77% 40
2022
Q1
$2.39M Buy
+29,112
New +$2.3M 0.55% 41

Other funds holding MRK

Cyrus J. Lawrence's MRK Position: Q1 2025 in Review

Cyrus J. Lawrence sold out of Merck (MRK) in Q1 2025, closing a stake of 7,106 shares — an estimated $706K sold.

Cyrus J. Lawrence first reported a position in MRK in Q1 2022 and held it in 10 quarters. The position peaked at $9.22M in Q3 2023. 3,454 funds tracked by Wall St. Rank hold MRK as of Q1 2025.

  • Cyrus J. Lawrence reported no remaining Merck position as of Q1 2025 after selling out during the quarter.
  • Cyrus J. Lawrence sold 7,106 Merck shares in Q1 2025, an estimated $706K.
  • Cyrus J. Lawrence first reported a position in Merck in Q1 2022 and held it in 10 quarters.
  • Cyrus J. Lawrence's Merck position peaked at $9.22M in Q3 2023.
  • 3,454 funds tracked by Wall St. Rank held Merck as of Q1 2025.

Based on Cyrus J. Lawrence's 13F filing for Q1 2025, filed 15 May 2025.